Welcome to our dedicated page for The Beauty Health Company SEC filings (Ticker: SKIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Beauty Health Company (NASDAQ: SKIN) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a medtech meets beauty business in skin health and aesthetics. This page aggregates those SEC filings and pairs them with AI-powered summaries to help readers interpret the information more efficiently.
Investors can use this resource to access current reports on Form 8-K, where BeautyHealth discloses material events such as quarterly financial results, leadership transitions, board appointments, debt and indenture changes, and amendments to its certificate of incorporation. For example, recent 8-K filings discuss the appointment of a new President and Chief Executive Officer, the appointment of a new independent director, a supplemental indenture related to 7.95% convertible senior notes due 2028, and a certificate of correction to its charter.
In addition to 8-Ks, the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available in the feed) provide detail on net sales, gross margin, adjusted EBITDA, delivery systems sold, active install base, regional performance, risk factors, and capital structure. These filings outline how BeautyHealth combines delivery systems and consumables in its revenue model and how it reports non-GAAP measures alongside GAAP results.
This page also offers easy access to insider and equity-related filings, such as Forms 3, 4, and 5 when they are filed, which can show transactions by directors and officers, as well as proxy and governance documents that describe director compensation, board structure, and key agreements. AI-generated explanations help clarify complex sections, highlight important changes, and point out items that may matter most to shareholders, analysts, and anyone researching SKIN’s regulatory history.
The Beauty Health Company appointed Hatem Malha as President, CEO and director and disclosed the material terms of his employment agreement. His base salary will be $800,000 per year (pro-rated if partial year). He will receive a $450,000 one-time cash bonus payable within 14 days of the effective date that is repayable if he resigns without specified cause or is fired for cause within 12 months. He is eligible for an annual performance bonus targeted at 125% of base salary and two one-time equity awards: an Initial equity grant of $2,556,000 split 75% in RSUs and 25% in PSUs, and a 2025 equity grant of $2,000,000 split 75% RSUs and 25% PSUs, each subject to board approval and the company's Incentive Plan vesting terms.
Mirabella Financial Services LLP reported beneficial ownership of 12,790,383 shares of Beauty Health Company (common stock), representing 10.21% of the class. The filing states these shares are held on behalf of Blue Riband Fund LP, for which Mirabella acts as investment manager and has sole voting and dispositive power over the reported shares. The filing notes the holdings were acquired in the ordinary course of business and not for the purpose of changing or influencing control. The issuer's principal executive office is listed in Long Beach, California.
The Beauty Health Company (SKIN) filed a Current Report on Form 8-K reporting a material event dated September 4, 2025. The filing incorporates by reference a Supplemental Indenture No. 1 dated September 4, 2025 among The Beauty Health Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, acting as trustee and collateral agent. The document includes an exhibit list and an embedded Inline XBRL cover page data file. The report is signed by Michael Monahan, Chief Financial Officer.
Janus Henderson Group plc reports beneficial ownership of 5,718,565 shares of The Beauty Health Company, representing 4.5% of the class. The filing indicates shared voting and shared dispositive power over those shares while noting no sole voting or dispositive power. The reporting person is organized in Jersey and identified as an investment adviser/holding company (IA, HC). The statement also discloses that indirect subsidiaries (JHIUS, JHIUKL and JHIAIFML) act as registered investment advisers providing advice to Managed Portfolios.
The Beauty Health Company (SKIN) Form 4 reports a non-sale withholding of shares by Chief Financial Officer Michael P. Monahan related to the vesting of restricted stock units. On 08/10/2025, 32,357 shares were withheld to satisfy tax withholding at a recorded price of $1.89 per share. The disclosure states this withholding "does not represent a sale." Following the transaction, the reporting person’s beneficial ownership is shown as 1,326,305 shares.
This filing documents an internal compensation settlement (tax withholding on vested RSUs) rather than an open-market transaction, and it clarifies the officer’s post-transaction share count.
Form 4 Overview – The Beauty Health Company (SKIN)
Director Desiree Gruber filed a Form 4 reporting the award of 73,051 Class A common-stock RSUs on 16 June 2025. The award was coded “A” (acquired) and represents equity compensation rather than an open-market purchase. After this grant, Gruber’s total beneficial ownership rises to 192,565 shares, all held directly.
Vesting Terms
- The RSUs vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the 2026 annual meeting of shareholders.
- Continuous board service is required through the vesting date.
Key Takeaways for Investors
- The filing signals continued board-level alignment with shareholders, although the grant is part of the regular director compensation program rather than a discretionary purchase.
- No derivative securities transactions were reported, and no shares were disposed of.
- The transaction does not alter the company’s cash position or share count today, but it will have a modest dilutive effect upon vesting.
FAQ
What is the current stock price of The Beauty Health Company (SKIN)?
What is the market cap of The Beauty Health Company (SKIN)?
